 People in China will now be able to get their hands on the latest weight loss drugs. Eli Lilly's Manjaro has landed Chinese regulatory approval for weight loss less than a month after a similar therapy for Novo Nordisk. The move fuels competition in a nation that's among the world's most severely hit by obesity.